Sergei Gryaznov
2022
In 2022, Sergei Gryaznov earned a total compensation of $770.9K as Chief Scientific Officer at MAIA Biotechnology, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $145,200 |
|---|---|
| Option Awards | $246,110 |
| Salary | $339,625 |
| Other | $39,944 |
| Total | $770,879 |
Gryaznov received $339.6K in salary, accounting for 44% of the total pay in 2022.
Gryaznov also received $145.2K in bonus, $246.1K in option awards and $39.9K in other compensation.
Rankings
In 2022, Sergei Gryaznov's compensation ranked 3,582nd out of 5,760 executives tracked by ExecPay. In other words, Gryaznov earned more than 37.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,582 out of 5,760 | 38th |
Division Manufacturing | 2,035 out of 3,136 | 35th |
Major group Chemicals And Allied Products | 975 out of 1,422 | 31st |
Industry group Drugs | 912 out of 1,323 | 31st |
Industry Pharmaceutical Preparations | 665 out of 969 | 31st |
Source: SEC filing on April 19, 2023.
Gryaznov's colleagues
We found three more compensation records of executives who worked with Sergei Gryaznov at MAIA Biotechnology in 2022.